Robert L. Charnas - Concepedia

Author

Robert L. Charnas

Roche (Switzerland)

Also Known As

R Charnas, R. Charnas, R. L. Charnas, ROBERT CHARNAS, Robert Charnas, Robert L. Charnas, Robert Louis Charnas

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)Cornell University Regeneron (United States)Moffitt Cancer Center Rutgers Cancer Institute

About

Robert L. Charnas is an author at Roche (Switzerland) specializing in biochemistry, microbiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	5	5	470
2	Health Sciences	3	3	145
3	Medicine	3	3	382
4	Natural Sciences	2	2	44
5	Public Health	1	1	82

Robert L. Charnas

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Refined crystal structure of β-lactamase from Citrobacter freundiiindicates a mechanism for β-lactam hydrolysis Christian Oefner, A. D’Arcy, J. J. Daly, Nature Crystal StructureBiochemistryBacteriologyProtein X-ray CrystallographyStructure-function Enzyme Kinetics	1990	298
Kinetic studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid Jed F. Fisher, Robert L. Charnas, Jeremy R. Knowles Biochemistry	1978	203
Inactivation of the RTEM .beta.-lactamase from Escherichia coli. Interaction of penam sulfones with the enzyme Jed F. Fisher, Robert L. Charnas, Scott M. Bradley, Biochemistry	1981	109
β-Lactamase inactivation by mechanism-based reagents J. W. Fisher, Joel G. Belasco, Robert L. Charnas, Philosophical transactions of the Royal Society of London. Series B, Biological sciences	1980	82
Chemical studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid Robert L. Charnas, Jed F. Fisher, Jeremy R. Knowles Biochemistry BacteriologyAltmetric Attention ScoreBacterial PathogensJeremy R. KnowlesciteFood Microbiology	1978	82
Structure-Based Design of β-Lactamase Inhibitors. 1. Synthesis and Evaluation of Bridged Monobactams Ingrid Heinze‐Krauss, Peter Angehrn, Robert L. Charnas, Journal of Medicinal Chemistry	1998	74
Inhibition of the RTEM .beta.-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid Robert L. Charnas, Jeremy R. Knowles Biochemistry	1981	69
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer Robert L. Charnas, ANNETTE RIDOLFI LÜTHI, Willy Ruch The Pediatric Infectious Disease Journal	1997	68
Inactivation of radiolabeled RTEM .beta.-lactamase from Escherichia coli by clavulanic acid and 9-deoxyclavulanic acid Robert L. Charnas, Jeremy R. Knowles Biochemistry	1981	67
Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL) Rajat Bannerji, John N. Allan, Jon Arnason, Blood	2019	55

Page 1